Sage Therapeutics
SAGE
#7363
Rank
NZ$0.52 B
Marketcap
$8.65
Share price
-5.49%
Change (1 day)
-73.08%
Change (1 year)

Operating Margin for Sage Therapeutics (SAGE)

Operating Margin as of November 2024 (TTM): -317.29%

According to Sage Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -317.29%. At the end of 2023 the company had an Operating Margin of -626.32%.

Operating Margin history for Sage Therapeutics from 2019 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-626.32%-90.96%
2022-6,931.88%-4.51%
2021-7,258.91%-13444.72%
202054.40%-100.55%
2019-9,904.46%2297.82%
2018-413.06%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-118.00%-62.81%๐Ÿ‡บ๐Ÿ‡ธ USA
13.84%-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
14.06%-104.43%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-59.02%-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.